Neurotransmitter release

Neurotransmitter release is the process by which a signalling neuron ejects its chemical messengers into the synapse — the narrow gap that separates it from its target. It is the moment of chemical communication: an electrical impulse that has travelled the length of the neuron is converted into a molecular signal that can cross to the receiving cell.

The transmitters themselves — dopamine, serotonin, glutamate, GABA, and many others — are stored in tiny membrane-bound pouches called vesicles, clustered at the tip of the axon terminal. Their contents determine what kind of signal is sent. Understanding this step matters because many substances intervene here, before any receptor is ever reached.

How it works · its role

When an action potential arrives at the axon terminal, it opens voltage-gated calcium channels in the membrane. Calcium ions pour in, and within milliseconds this triggers vesicles to fuse with the terminal wall and empty their contents into the synaptic cleft — a process coordinated by a family of proteins called SNAREs.

Once in the cleft, transmitter molecules diffuse to receptors on the receiving neuron, producing excitation or inhibition. The signal is then ended: transporter proteins pump most of the transmitter back into the releasing neuron for repackaging, while enzymes break down whatever remains. A single release event is small — a few thousand molecules — but the coordinated firing of millions of synapses produces the full range of mood, thought, and sensation.

Relevance to substances & effects

Many substances act at the release step rather than — or in addition to — the receptors that receive the signal. Where in the cycle a substance intervenes shapes both its subjective effects and its risk profile.

Releasing agents — amphetamines and MDMA — drive transmitter molecules out through the reuptake transporters in reverse, without any action potential required. The result is a rapid, unregulated surge of dopamine, serotonin, and norepinephrine: the stimulant rush and, in MDMA's case, the characteristic emotional warmth.

Presynaptic inhibitors act in the opposite direction. Opioids bind to receptors on the terminal itself, reducing calcium entry and slowing transmitter output. Cannabinoids work as retrograde signals, travelling back across the synapse to quiet the neuron that fired. Both produce a general dampening — pain suppression, reduced anxiety, sedation — through reduced chemical output rather than direct receptor blockade.

Some substances deplete the vesicle stores before release can occur. Reserpine, once used as an antihypertensive, blocks the pumps that load transmitter into vesicles; the resulting depletion of stored monoamines carries a pronounced risk of depression, illustrating how tightly mood is coupled to transmitter availability.